ATE290854T1 - Carbamazepinformulierung mit verzögerter freigabe - Google Patents
Carbamazepinformulierung mit verzögerter freigabeInfo
- Publication number
- ATE290854T1 ATE290854T1 AT00650026T AT00650026T ATE290854T1 AT E290854 T1 ATE290854 T1 AT E290854T1 AT 00650026 T AT00650026 T AT 00650026T AT 00650026 T AT00650026 T AT 00650026T AT E290854 T1 ATE290854 T1 AT E290854T1
- Authority
- AT
- Austria
- Prior art keywords
- carbamazepine
- release formulation
- supported
- active ingredient
- sustained release
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/292,609 US6162466A (en) | 1999-04-15 | 1999-04-15 | Sustained release formulation of carbamazepine |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE290854T1 true ATE290854T1 (de) | 2005-04-15 |
Family
ID=23125414
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00650026T ATE290854T1 (de) | 1999-04-15 | 2000-04-06 | Carbamazepinformulierung mit verzögerter freigabe |
Country Status (10)
Country | Link |
---|---|
US (1) | US6162466A (de) |
EP (1) | EP1044681B1 (de) |
AT (1) | ATE290854T1 (de) |
AU (1) | AU761441B2 (de) |
CA (1) | CA2303973C (de) |
DE (1) | DE60018629T2 (de) |
ES (1) | ES2238982T3 (de) |
NZ (1) | NZ503772A (de) |
SG (1) | SG91270A1 (de) |
ZA (1) | ZA200001852B (de) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7612112B2 (en) * | 2001-10-25 | 2009-11-03 | Depomed, Inc. | Methods of treatment using a gastric retained gabapentin dosage |
US20070184104A1 (en) * | 2001-10-25 | 2007-08-09 | Depomed, Inc. | Gastric retentive gabapentin dosage forms and methods for using same |
TWI312285B (en) | 2001-10-25 | 2009-07-21 | Depomed Inc | Methods of treatment using a gastric retained gabapentin dosage |
US6572889B1 (en) * | 2002-03-07 | 2003-06-03 | Noveon Ip Holdings Corp. | Controlled release solid dosage carbamazepine formulations |
CA2572928A1 (en) | 2004-07-22 | 2006-02-26 | Amorepacific Corporation | Sustained-release preparations containing topiramate and the producing method thereof |
EP1877040A1 (de) * | 2005-04-25 | 2008-01-16 | Teva Pharmaceuticals USA, Inc. | Formulierungen mit verlängerter freisetzung |
US8497258B2 (en) | 2005-11-12 | 2013-07-30 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
US20090176882A1 (en) * | 2008-12-09 | 2009-07-09 | Depomed, Inc. | Gastric retentive gabapentin dosage forms and methods for using same |
US8703191B2 (en) * | 2006-07-25 | 2014-04-22 | Intelgenx Corp. | Controlled-release pharmaceutical tablets |
US7674479B2 (en) * | 2006-07-25 | 2010-03-09 | Intelgenx Corp. | Sustained-release bupropion and bupropion/mecamylamine tablets |
CN101129384B (zh) * | 2007-09-06 | 2011-07-20 | 河南天方药业股份有限公司 | 一种制备卡马西平缓释胶囊的方法 |
US20100285119A1 (en) * | 2008-01-11 | 2010-11-11 | Jubilant Organosys Ltd. | Multiparticulate Extended Release Pharmaceutical Composition Of Carbamazepine And Process For Manufacturing The Same |
CN101647784B (zh) * | 2008-08-15 | 2012-04-11 | 北京科信必成医药科技发展有限公司 | 卡马西平缓释片及其制备方法 |
US20110097401A1 (en) | 2009-06-12 | 2011-04-28 | Meritage Pharma, Inc. | Methods for treating gastrointestinal disorders |
US20110136815A1 (en) | 2009-12-08 | 2011-06-09 | Horst Zerbe | Solid oral film dosage forms and methods for making same |
US10610528B2 (en) | 2009-12-08 | 2020-04-07 | Intelgenx Corp. | Solid oral film dosage forms and methods for making same |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5326570A (en) * | 1991-07-23 | 1994-07-05 | Pharmavene, Inc. | Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine |
JP3116648B2 (ja) * | 1993-04-13 | 2000-12-11 | 株式会社豊田自動織機製作所 | 荷役用油圧制御装置 |
DE4423078B4 (de) * | 1994-07-01 | 2005-01-13 | Awd.Pharma Gmbh & Co. Kg | Verfahren zur Herstellung einer Carbamazepin-Arzneiform mit verzögerter Wirkstofffreisetzung |
JPH08157392A (ja) * | 1994-12-01 | 1996-06-18 | Kanegafuchi Chem Ind Co Ltd | 放出制御型製剤 |
US5980942A (en) * | 1997-01-23 | 1999-11-09 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Zero-order sustained release matrix tablet formulations of carbamazepine |
US6514530B2 (en) * | 1997-09-09 | 2003-02-04 | Alza Corporation | Dosage form comprising means for changing drug delivery shape |
DE19845358A1 (de) * | 1998-10-02 | 2000-04-06 | Roehm Gmbh | Überzogene Arzneiformen mit kontrollierter Wirkstoffabgabe |
-
1999
- 1999-04-15 US US09/292,609 patent/US6162466A/en not_active Expired - Lifetime
-
2000
- 2000-04-05 AU AU26413/00A patent/AU761441B2/en not_active Ceased
- 2000-04-06 NZ NZ503772A patent/NZ503772A/en unknown
- 2000-04-06 AT AT00650026T patent/ATE290854T1/de not_active IP Right Cessation
- 2000-04-06 CA CA002303973A patent/CA2303973C/en not_active Expired - Fee Related
- 2000-04-06 ES ES00650026T patent/ES2238982T3/es not_active Expired - Lifetime
- 2000-04-06 DE DE60018629T patent/DE60018629T2/de not_active Expired - Lifetime
- 2000-04-06 EP EP00650026A patent/EP1044681B1/de not_active Expired - Lifetime
- 2000-04-07 SG SG200001988A patent/SG91270A1/en unknown
- 2000-04-12 ZA ZA200001852A patent/ZA200001852B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
EP1044681B1 (de) | 2005-03-16 |
AU2641300A (en) | 2000-10-19 |
US6162466A (en) | 2000-12-19 |
DE60018629T2 (de) | 2006-04-13 |
CA2303973C (en) | 2009-12-22 |
AU761441B2 (en) | 2003-06-05 |
DE60018629D1 (de) | 2005-04-21 |
EP1044681A3 (de) | 2002-01-02 |
EP1044681A2 (de) | 2000-10-18 |
NZ503772A (en) | 2001-06-29 |
SG91270A1 (en) | 2002-09-17 |
ZA200001852B (en) | 2001-02-20 |
CA2303973A1 (en) | 2000-10-15 |
ES2238982T3 (es) | 2005-09-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE290854T1 (de) | Carbamazepinformulierung mit verzögerter freigabe | |
DE69919713D1 (de) | Pharmazeutische zubereitung mit verzögerter wirkstofffreisetzung von phenytoin natrium | |
FR2774288B1 (fr) | Microgranules d'omeprazole gastroproteges, procede d'obtention et preparations pharmaceutiques | |
ATE332126T1 (de) | Geschmacksmaskierte pharmazeutische zusammensetzungen | |
WO2003103637A3 (en) | MODIFIED RELEASE MULTIPLE UNIT DRUG DELIVERY SYSTEMS | |
DE69723303D1 (de) | Arzneimittel mit verzögerter wirkstoffabgabe | |
CA2258095A1 (en) | Tetrahydrolipstatin containing compositions | |
HK1053602A1 (en) | Ropinirole-containing hydrophilic/liphilic polymeric matrix dosage formulation | |
ATE464885T1 (de) | Verfahern zur herstellung von festen verabreichungssystemen für eingekapselte und nicht-eingekapselte pharmazeutische wirkstoffe | |
FR2683146B1 (fr) | Compositions pharmaceutiques a liberation reglee de la substance medicamenteuse. | |
DE69519685T2 (de) | Oral anzuwendende arzneizubereitung mit verzögerter wirkstoffabgabe | |
ATE235234T1 (de) | Mesalazine enthaltende pharmazeutische zusammensetzungen mit gesteuerte freisetzung | |
HUP0203451A2 (hu) | Új, tuberkolózis elleni gyógyszerkészítmények és eljárás előállításukra | |
BR9917012A (pt) | Comprimido matricial, permitindo a liberação prolongada de gliclazida, após administração por via oral | |
AU2002214305A1 (en) | Pharmaceutical preparation containing copolyvidone | |
HUP0003840A2 (hu) | Szabályozott hatóanyagleadású gyógyászati készítmények | |
RS50298B (sr) | Direktno kompresibilna matrica za kontrolisano oslobađanje pojedinačnih dnevnih doza klaritromicina | |
ATE304844T1 (de) | Entzündungshemmende pharmazeutische formulierungen | |
ATE247981T1 (de) | Proteinenthaltende pharmazeutische zubereitung | |
WO2002013762A3 (en) | Improved solid pharmaceutical dosage formulation of hydrophobic drugs | |
BR9608392A (pt) | Preparação multiparticulada de liberação controlada e forma de dosagem em tablete. | |
GEP20043377B (en) | Pharmaceutical Complex | |
ATE234608T1 (de) | Mikrokapseln mit verzögerter freisetzung von wirkstoffen | |
DE69914472D1 (de) | Levosimendanhaltige oral anzuwendende arzneimittel mit gesteuerter wirkstoffverabreichung | |
ATE169818T1 (de) | Carbamazepin-arzneiform mit verzögerter wirkstofffreisetzung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |